In HCC, TAMs upregulate cyclooxygenase-2 (COX2) and prostaglandin E synthase 1 (PGES1) to produce high levels of PGE2, which inhibits IFN-γ production and NK cell cytotoxicity (55). The gene discussed is PTGS2; the disease is hepatocellular carcinoma.